Q32 Bio (QTTB) Stock Forecast, Price Target & Predictions
QTTB Stock Forecast
Q32 Bio stock forecast is as follows: an average price target of $63.80 (represents a 119.32% upside from QTTB’s last price of $29.09) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
QTTB Price Target
The average price target for Q32 Bio (QTTB) is $63.80 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $95.00 to $45.00. This represents a potential 119.32% upside from QTTB's last price of $29.09.
QTTB Analyst Ratings
According to 5 Wall Street analysts, Q32 Bio's rating consensus is 'Buy'. The analyst rating breakdown for QTTB stock is 1 'Strong Buy' (20.00%), 4 'Buy' (80.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Q32 Bio Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | Jay Olson | Oppenheimer | $80.00 | $48.47 | 65.05% | 175.01% |
| Sep 11, 2024 | Derek Archila | Wells Fargo | $95.00 | $50.61 | 87.73% | 226.57% |
| May 21, 2024 | Thomas Smith | Leerink Partners | $54.00 | $30.20 | 78.81% | 85.63% |
| Apr 10, 2024 | Jay Olson | Oppenheimer | $50.00 | $21.48 | 132.77% | 71.88% |
| Apr 02, 2024 | Christopher Raymond | Raymond James | $45.00 | $18.00 | 150.00% | 54.69% |
| Apr 02, 2024 | Allison Bratzel | Piper Sandler | $45.00 | $18.00 | 150.00% | 54.69% |
The latest Q32 Bio stock forecast, released on Oct 16, 2024 by Jay Olson from Oppenheimer, set a price target of $80.00, which represents a 65.05% increase from the stock price at the time of the forecast ($48.47), and a 175.01% increase from QTTB last price ($29.09).
Q32 Bio Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 6 |
| Avg Price Target | - | $87.50 | $61.50 |
| Last Closing Price | $29.09 | $29.09 | $29.09 |
| Upside/Downside | -100.00% | 200.79% | 111.41% |
In the current month, the average price target of Q32 Bio stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Q32 Bio's last price of $29.09. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 23, 2024 | Raymond James | - | Strong Buy | Initialise |
| Oct 16, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 11, 2024 | Wells Fargo | - | Overweight | Initialise |
| Jun 17, 2024 | Guggenheim | - | Buy | Initialise |
| Apr 02, 2024 | Piper Sandler | - | Overweight | Initialise |
Q32 Bio's last stock rating was published by Raymond James on Oct 23, 2024. The company Initialise its QTTB rating from "null" to "Strong Buy".
Q32 Bio Financial Forecast
Q32 Bio Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Q32 Bio's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. QTTB's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Q32 Bio EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict QTTB's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Q32 Bio's previous annual EBITDA (undefined) of $NaN.
Q32 Bio Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Q32 Bio's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. QTTB's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Q32 Bio SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Q32 Bio's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to QTTB last annual SG&A of $NaN (undefined).
Q32 Bio EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Q32 Bio's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to QTTB previous annual EPS of $NaN (undefined).